DUBLIN, Dec. 11, 2014 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/cscdh8/inhaled_copd) has announced the addition of the "Inhaled COPD Therapeutics" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral COPD inhalers, half of which are two-drug combination products, include design elements that attempt to address the unique and challenging treatment factors associated with COPD. The resulting devices are user-friendly and incorporate designed-in safety features, and in the process support the parallel goal of improved compliance. While not curative, these inhalable drug products provide patients with symptomatic relief while reducing the morbidity associated with this progressive disease.
Highlights
- Analyzes therapeutic drugs and pipeline candidates delivered via oral inhalers for treating COPD
- Assesses inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
- Provides detailed assessments of inhaled drug targeted disease segments, growth prospects and market potential
- Provides market data and forecasts for inhaled COPD therapeutic drugs to 2020
- Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners
Key Topics Covered:
Executive Summary
COPD Therapeutics Market Dynamics
- Devices, Formulations and Market Evolution
- Established Therapeutic Targets
- Competing Dosage Forms
- Prescribing Trends
- Therapeutic Strategies
- Factors Driving Growth
COPD Technology & Product Development Factors
- Drug Formulations & Formulation Technologies
- Inhalation Device Design Factors
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
- Dose Reproducibility
- Active Compound Stability
- Emerging Device Technologies
COPD Inhaler Design Factors
- Novel Formulation Technology
- Patient-friendly Administration/Coaching Technology
- User Confirmation/Feedback/Disease Management
- Embedded Electronics
- Combination (multidrug) Inhalers
Inhaled COPD Product Analysis, Market Data & Forecasts
- Anticholinergics
- Anticholinergic/SABA
- Antocholinergic/LABA
- ICS/LABA
- LABA
- Other Important/Emerging Drug Classes
Market Factors
- Regulations and Standards
- Clinical Trials
- Healthcare Economics
- Managed Care and Payor Initiatives
Company Profiles
For more information visit http://www.researchandmarkets.com/research/cscdh8/inhaled_copd
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article